Ordering happens through an online shop with a real-time inventory listing, and the range is built around human immune cells: normal, irradiated and disease-state PBMC; pan CD3+, CD4+, CD8+, regulatory and antigen-specific T cells; B cells and B-lymphoblastoid cell lines; dendritic cells; monocytes; isolated and expanded NK cells; neutrophils; whole and peptide antigens; and normal and diseased plasma. Donors are characterized for ethnicity and HLA type and can be recalled for repeat draws, each lot is sterility tested, and products ship with a lot-specific Certificate of Analysis carrying donor detail and recommended thaw procedures. Collections are taken at licensed centers under informed consent and institutional review board oversight, and everything is sold for research use only. Custom development reaches cord blood-derived stem cells, and the scientific team also advises on cell-based assay choice, study design and biomaterial selection.
Ignyte Bio
Ignyte Bio is a specialized scientific consulting and strategic marketing firm focused on propelling early-stage biotech companies, research tools providers, and life science platforms toward commercial success. Combining deep technical understanding with commercial expertise, Ignyte Bio designs high-impact growth strategies, market positioning, and digital content that resonates with the global scientific community.
